Mary Ann Gray's Net Worth

$2.92 Million

Estimate Recalculated Nov 11, 2024 08:46AM EST

Who is Mary Ann Gray?

Mary Ann Gray has an estimated net worth of $2.92 Million. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, Keros Therapeutics, Inc., Sarepta Therapeutics, Inc., RAPT Therapeutics, Inc., ACADIA PHARMACEUTICALS INC, GALENA BIOPHARMA, INC., BioAtla, Inc., Seneca Biopharma, Inc., JUNIPER PHARMACEUTICALS INC, Compass Therapeutics, Inc., DYAX CORP, SENOMYX INC, TELIK INC, and GTC BIOTHERAPEUTICS INC.

SEC CIK

Mary Ann Gray's CIK is 0001261974

Past Insider Trading and Trends

2016 was Mary Ann Gray's most active year for acquiring shares with 17 total transactions. Mary Ann Gray's most active month to acquire stocks was the month of May. 2016 was Mary Ann Gray's most active year for disposing of shares, totalling 14 transactions. Mary Ann Gray's most active month to dispose stocks was the month of December. 2016 saw Mary Ann Gray paying a total of $1,833,343.01 for 699,250 shares, this is the most they've acquired in one year. In 2014 Mary Ann Gray cashed out on 24,500 shares for a total of $388,815.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TETRALOGIC PHARMACEUTICALS Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 28
Form 4
—
0
—
—
0
Nov 5
Form 3
—
0
—
—
0
No matching records found

Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Dec 17
Form 3
—
0
—
—
0
No matching records found

Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $128.92

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+31.40%
2.95K
—
—
12.36K
Mar 7
Form 4
+11.46%
967
—
—
9.4K
Dec 10
Form 4
+47.74%
2.73K
—
—
8.44K
Mar 3
Form 4
+20.39%
967
—
—
5.71K
Dec 10
Form 4
+77.77%
2.08K
—
—
4.74K
Feb 28
Form 4
+56.85%
967
—
—
2.67K
Dec 10
Form 4
+2,401.47%
1.63K
—
—
1.7K
Mar 4
Form 4
—
0
—
—
0
Dec 10
Form 3
—
0
—
—
0
No matching records found

RAPT Therapeutics, Inc. (RAPT) Snapshot price: $1.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Mar 28
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 4
Form 3
—
0
—
—
0
No matching records found

ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.52%
16.64K
$9.04
$150,398.48
149.48K
Jun 7
Form 4
∞
132.84K
$1.33
$176,599.52
132.84K
Apr 7
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
$23.00
-$102,000.00
0
Scheduled
Jan 13
Form 4
—
0
$20.60
-$273,035.00
0
Scheduled
Dec 15
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
$14.45
-$186,961.00
0
Scheduled
Aug 26
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Sep 9
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Apr 27
Form 3
—
0
—
—
0
No matching records found